A Review of the Use of Clonidine as a Sleep Aid in the Child and Adolescent Population

Abstract

Get full access to this article

View all access options for this article.

References

Clonidine hydrochloride [package insert]. Ridgefield, CT: Boehringer Ingelheim Pharmaceuticals, Inc; October 2009. http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/017407s034lbl.pdf. Accessed October 12, 2012.

Arnsten

Scahill

Findling

. α2-Adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data. J Child Adolesc Psychopharmacol. 2007;17:393-406.

Hunt

Minderaa

Cohen

. Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial. J Am Acad Child Psychiatry. 1985;24:617-629.

Kapvay (clonidine hydrochloride) extended-release tablets [package insert]. Atlanta, GA: Shionogi Pharma, Inc; September 2010. http://www.kapvay.com/pdf/Kapvay_final_09.28.10.pdf. Accessed December 24, 2012.

Intuniv (guanfacine) extended-release tablets [package insert]. Wayne, PA: Shire US, Inc; June 2011. http://pi.shirecontent.com/PI/PDFs/Intuniv_USA_ENG.pdf. Accessed December 24, 2012.

Kemph

DeVane

Levin

Jarecke

Miller

. Treatment of aggressive children with clonidine: results of an open pilot study. J Am Acad Child Adolesc Psychiatry. 1993;32:577-581.

Lowenthal

Matzek

MacGregor

. Clinical pharmacokinetics of clonidine. Clin Pharmacokinet. 1988;14:287-310.

Croxtall

. Clonidine extended-release in attention-deficit hyperactivity disorder. Pediatr Drugs. 2011;13:329-336.

Catapres-TTS (clonidine) [package insert]. Ridgefield, CT: Boehringer Ingelheim Pharmaceuticals, Inc; May 2012. http://bidocs.boehringer-ingelheim.com/BIWebAccess/ViewServlet.ser?docBase=renetnt&folderPath=/Prescribing+Information/PIs/Catapres+TTS/CatapresTTS.pdf. Accessed December 24, 2012.

10.

Delbarre

Schmitt

. Sedative effects of alpha-sympathomimetic drugs and their antagonism by adrenergic and cholinergic blocking drugs. Eur J Pharmacol. 1971;13:356-363.

11.

Holman

Shillito

Vogt

. Sleep produced by clonidine (2-(2,6-dichlorophenylamino)-2-imidazole hydrochloride). Br J Pharmacol. 1971;43:685-695.

12.

Owens

Rosen

Mindell

Kirchner

. Use of pharmacotherapy for insomnia in child psychiatry practice: a national survey. Sleep Med. 2010;11:692-700.

13.

Owens

Babcock

Blumer

. The use of pharmacotherapy in the treatment of pediatric insomnia in primary care: rational approaches. A consensus meeting summary. J Clin Sleep Med. 2005;1:49-59.

14.

Trommer

Hoeppner

Rosenberg

Armstrong

Rothstein

. Sleep disturbances in children with attention deficit disorder. Ann Neurol. 1988;24:325-332.

15.

Stein

. Unravelling sleep problems in treated and untreated children with ADHD. J Child Adolesc Psychopharmacol. 1999;9:157-168.

16.

Steingard

Biederman

Spencer

Wilens

Gonzalez

. Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorders. J Am Acad Child Adolesc Psychiatry. 1993;32:350-353.

17.

Owens

Rosen

Mindel

. Medication use in the treatment of pediatric insomnia: results of a survey of community-based pediatricians. Pediatrics. 2003;111(5 pt 1):e628-e635.

18.

Efron

Hiscock

Sewell

. Prescribing of psychotropic medications for children by Australian pediatricians and child psychiatrists. Pediatrics. 2003;111:372-375.

19.

Prince

Wilens

Biederman

Spencer

Wozniak

. Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases. J Am Acad Child Adolesc Psychiatry. 1996;35:599-605.

20.

Owens

. The practice of pediatric sleep medicine: results of a community survey. Pediatrics. 2001;108:E51.

21.

Wilens

Biederman

Spencer

. Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1994;33:424-426.

22.

Hollway

Aman

. Pharmacological treatment of sleep disturbance in developmental disabilities: a review of the literature. Res Dev Disabil. 2011;32:939-962.

23.

Ming

Gordon

Kang

Wagner

. Use of clonidine in children with autism spectrum disorders. Brain Dev. 2008;30:454-460.

24.

Fankhauser

Karumanchi

German

Yates

Karumanchi

. A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism. J Clin Psychiatry. 1992;53:77-82.

25.

Ingrassia

Turk

. The use of clonidine for severe and intractable sleep problems in children with neurodevelopmental disorders—a case series. Eur Child Adolesc Psychiatry. 2005;14:34-40.

26.

Feron

Hendriksen

Nicolai

Vles

. New-onset seizures: a possible association with clonidine? Pediatr Neurol. 2008;38:147-149.

27.

Gutgesell

Atkins

Barst

. AHA scientific statement: cardiovascular monitoring of children and adolescents receiving psychotropic drugs. J Am Acad Child Adolesc Psychiatry. 1999;38:1047-1050.

28.

Pliszka

, AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46:894-921.

29.

Horacek

. Extended-release clonidine for sleep disorders. J Am Acad Child Adolesc Psychiatry. 1994;33:1210.

30.

Ghanizadeh

. Insomnia, night terror, and depression related to clonidine in attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. 2008;28:725-726.

31.

Kappagoda

Schell

Hanson

Hutchins

. Clonidine overdose in childhood: implications of increased prescribing. J Paediatr Child Health. 1998;34:508-512.

32.

Klein-Schwartz

. Trends and toxic effects from pediatric clonidine exposures. Arch Pediatr Adolesc Med. 2002;156:392-396.

33.

Spiller

Klein-Schwartz

Colvin

Villalobos

Johnson

Anderson

. Toxic clonidine ingestion in children. J Pediatr. 2005;146:263-266.